All attending UK organisations

UK companies attendingBIO-Europe Spring as part of the official virtual delegation

(Click here to search profiles):

UK Virtual Delegation
National Institute for Health Research (NIHR): virtual booth #9
Clinical Network Services (UK), Karma Oncology, MediWales, Pebmond Associates, UK Bioindustry Association.

Other UK companies associated with the delegation*:
Albumedix, Almac Discovery, AMR Centre, BioAscent Discovery, Bit Bio Limited, C4X Discovery, Catalyst Advisors, Crystec, e Therapeutics, Galen, Isogenica, Medherant, Mereo BioPharma Group, Microbiotica, Midatech Pharma, Orbit Discovery, ProAxsis Limited, Sekisui, Sygnature Discovery, Tissue Solutions.

All attending UK companies:
3M United Kingdom, Achilles Therapeutics, AdisInsight, Adnovate Clinical Development Strategies, Advanz Pharma, Albumedix, Almac Discovery, AMR Centre, APM Health Europe, Antev, Arctoris, Arecor Limited, Artemida Pharma Ltd, AstraZeneca, Asymchem Laboratories, Atelix Ltd, Barrington James, Bicycle Therapeutics, BicycleTX, BioAscent Discovery, BioCentury Inc, Biogen, BioPartner UK, BioPharma-Reporter, Bit Bio Limited, Black Swan Analysis, C4X Discovery, Cambrex, Charles River Laboratories, Chiesi, Citigate Dewe Rogerson, Clarivate Analytics, Clinical Network Services, Clinigen, Consilient Health, Coulter Partners, Covance, Crystec, cSubs, CV6 Therapeutics , Dementia Discovery Fund, Destiny Pharma, Diurnal Ltd, Domainex, e Therapeutics, EBD Academy, EBD Group, Eisai Europe, Eli Lilly and Company, Ellipses Pharma, Enplas Europe - CELL, Evotec International, Femtogenix, Fujifilm Diosynth Biotechnologies, Galen, GlobalData, Goodwin, GSK, Hematherix, Heptares Therapeutics, Histologix Ltd, Horton International, IAG, Informa Connect, IN-PART, IONTAS, IQVIA Drug News, Isogenica, J A Kemp, Johnson & Johnson, Karma Oncology, Kymab, Kyowa Kirin Co, LGC, Macrophage Pharma, Medherant, MediWales, MedPharm, Mereo BioPharma, Microbiotica, Midatech Pharma, Mission Therapeutics, Mitsubishi Tanabe Pharma Corporation, Mogrify, MSD, National Institute of Health (NIHR), Nature Research, Newcastle University, Norgine Ventures, One Nucleus, ONO pharma UK, Orbit Discovery, Otsuka Pharmaceutical, oval, Pebmond Associates, Pfizer CentreOne, Pharma Intelligence - Informa, Pharmalicensing, pharmaphorum, PharmaVentures, PhoreMost, Precision for Medicine, Oncology and Rare Disease, ProAxsis, Proclinical, ProPharma Group, Quotient Sciences, Randox Biosciences, ReNeuron Group, Results Healthcare, Sage Healthcare, Sanofi, SBA, Scius Communications, Sekisui, Simcere Pharmaceutical Group, Sygnature Discovery, Teijin Pharma, London Office, The Institute of Cancer Research, The RSA Group, Thermo Fisher Scientific, Tissue Solutions, Torreya, Transcrip Partners, Treehill Partners, UCB Pharma, UK Bioindustry Association, University of Warwick, Veriton Pharma, Vernalis R&D, Virdis Group, Waracle, WuXi Biologics.
132 correct at 17/03/2020

Join them here!